Blogs about DEPO - Stockpickr! Your Source for Stock Ideas

Blogs about DEPO

Blogs	Description	Date Updated
The 52-Week Low Club: Home Builders By The Ton	Already regular members, today's list includes Meritage (MTH), KB Home (KBH), Pulte (PHM), Lennar (LEN), and Beazer (BZH). Circuit City (CC) Electronics retail continues to disappoint. Down to $14.60 from $29.31 as 52-week high. Office Depot (ODP) Company blames slow economy for poor sales. Depomed Inc (DEPO) Biomed company runs into poor clinical trials, drops 60%. Shares down to $1.83 from 52-week high of $5.24. Physicians Formula (FACE) Cuts Q2 and full-year outlook. Down t...	July 10, 2007
StreetInsider.com Unusual 11 Mid-Day Movers 07/10/2007	FONAR Corporation (NASDAQ: FONR) 107.5% HIGHER; Reported today that the company has sold Seven UPRIGHT Multi-Position(TM) MRIs during the previous two weeks. By contrast, since this year began, sales by other MRI manufacturers have declined, with one major company reporting a quarterly imaging sales decline including MRI of $150 million. Ocean Bio-Chem, Inc. (Nasdaq: OBCI) 82.7% HIGHER; After the company reported Q2 net sales of approximately $5,722,000, compared to $4,332,000 for the 2nd qu...	July 10, 2007
Depomed (DEPO): Another Small Cap BioTech Implodes	Depomed (DEPO) is down over 60% today to $1.85, a new 52-week low. The stock has been as high as $5.83 during the period. It is yet another small cap biotech that was a "one trick pony". But, in this case, the pony died. According to the AP the company said "results of a late-stage clinical trial of its Gabapentin GR extended release tablet for nerve pain didn't show significant effectiveness versus placebo." There was not much to say for the company before the announcement. Last ...	July 10, 2007
Loeb's Third Point Shows A Number of New Positions in Latest 13F	Third Point LLC, run by activist investors Daniel Loeb, released its 13F for the quarter ended March 31, 2007 yesterday afternoon.Some interesting new positions from the filing:Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) 350,000 sharesAlexion Pharmaceuticals Inc. (Nasdaq: ALXN) 400,000 sharesAlkermes, Inc. (Nasdaq: ALKS) 750,000 sharesAriad Pharmaceuticals Inc. (Nasdaq: ARIA) 1,600,000 sharesATP Oil & Gas Corp. (Nasdaq: ATPG) 2,000,000 shares (already known from 13G)BearingPoint (NYSE: BE) 3,...	May 16, 2007
Loeb's Third Point Discloses 8.7% Stake in Candela (CLZR)	In a 13G filing on Candela Corporation (Nasdaq: CLZR), Daniel Loeb's Third Point LLC disclosed an 8.7% stake (2 million shares) in the company. The firm did not show a stake in CLZR for the quarter ended 12/31/06.A 13G filing indicates a "passive" stake, but Loeb is known as an activist investors. On Friday, Loeb also disclosed a new 5%+ stake in DepoMed Inc. (Nasdaq: DEPO).Candela manufactures, and distributes innovative clinical solutions that enable physicians, surgeons, and personal care pra...	May 14, 2007
Loeb's Third Point LLC Discloses 8.2% Stake in DepoMed (DEPO)	In a 13G filing after the close Friday, Daniel Loeb's Third Point LLC disclosed an 8.2% stake in DepoMed Inc. (Nasdaq: DEPO). The firm did not show a stake in DEPO for the quarter ended 12/31/06.A 13G indicates a "passive" stake, but Loeb is known as a activist investor.Depomed, Inc., is a specialty pharmaceutical company with two approved products on the market and multiple product candidates in its pipeline.You can get 13D reports and others e-mailed to you in real-time by signing up for Stre...	May 14, 2007

Enter search text here: